Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.

Information

  • Research Project
  • 8905526
  • ApplicationId
    8905526
  • Core Project Number
    R41HG008566
  • Full Project Number
    1R41HG008566-01
  • Serial Number
    008566
  • FOA Number
    PA-11-335
  • Sub Project Id
  • Project Start Date
    4/20/2015 - 11 years ago
  • Project End Date
    3/31/2017 - 9 years ago
  • Program Officer Name
    GILCHRIST, DANIEL A
  • Budget Start Date
    4/20/2015 - 11 years ago
  • Budget End Date
    3/31/2016 - 10 years ago
  • Fiscal Year
    2015
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/17/2015 - 11 years ago
Organizations

Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.

? DESCRIPTION (provided by applicant): The human transcriptome is significantly more complex than its cognate genome, due to the hundreds of thousands of possible isoforms, allele-specific expression issues, variable RNA editing changes, and differential expression patterns spanning cell types, developmental stages, and physiological stresses. Next- generation sequencing (NGS) platforms are fundamentally altering genetic and genomic research by providing massive amounts of data in a low-cost, high-throughput format. The main drawback of existing technologies is the short sequence read lengths they produce (Illumina) or the high error rate (PacBio). Identifying single nucleotide variations is problematic with the long read technology and de novo assembly of most transcripts is compromised with short read NGS technologies alone. Even with a high quality reference human genome (which is a mosaic of the parental alleles), transcriptome sequencing and assembly is a significant challenge. Haplotyping across an entire mRNA is critical for understanding the full extent of RNA editing and is not readily achieved without resorting to cloned DNA. New tools that bridge the gap between massively parallel short read sequencing technologies and the need to assemble complete mRNA molecules are clearly needed. The SBIR Phase I of this grant proposes to develop the short read NGS technology to accurately sequence mRNAs along their entire length, regardless of size. This technology will enable the accurate assembly of complex transcriptomes, without cDNA cloning and primer walking using Sanger sequencing based strategies. The development of these tools could enable the de novo sequencing of daunting transcriptomes, reduce computational costs of transcriptome assembly significantly, produce more complete and accurate catalogs of RNA edited transcripts, and make personal transcriptome resequencing tractable.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R41
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    350000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:350000\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LUCIGEN CORPORATION
  • Organization Department
  • Organization DUNS
    019710669
  • Organization City
    MIDDLETON
  • Organization State
    WI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    535621614
  • Organization District
    UNITED STATES